UltraSight

Name: UltraSight
Brand: UltraSight

UltraSight is an AI-assisted cardiac workflow solution that provides real-time mobile application guidance for transthoracic echocardiography acquisition, structured training, interpretation workflow integration, and analytics to support non-sonographer clinical providers under qualified physician oversight.

Est 2018|11 Ref Customers

LinkedIn 3K|Website|FTEs 39

Published Oct 7, 2026

01Common complaints

- Scenarios where alternatives may be preferable - If an organization requires a bundled handheld ultrasound hardware + cloud archive + education package with published list pricing, hardware-centric ecosystems such as Butterfly may offer simpler procurement for smaller programs. - If the primary need is automated measurements and structured reporting across multiple POCUS exam types (beyond cardiac acquisition guidance), platform/middleware approaches such as AISAP’s offerings may align better, subject to module clearance and integration verification. - Organization sizes or stages where UltraSight may be unsuitable - Small clinics without an echo governance structure, QA processes, and access to qualified over-readers may face operational challenges implementing a physician-oversight model. - Technical requirements the product may not meet - If broad device-agnostic support across many ultrasound systems is required without constraints, UltraSight’s compatibility requirements should be carefully evaluated. - Budget and workflow constraints - Enterprise quote-based pricing with additional professional services for training and stewardship may be difficult to justify for very low-volume sites. - If integration into PACS/VNA/EMR workflows is not possible or not desired, the product’s full value proposition may not be realized. - Limitations defined by regulatory scope and vendor documentation - FDA-cleared indications focus on assisting acquisition of specific standard 2D transthoracic views for adult patients, not on autonomous diagnosis or replacement of comprehensive echocardiography. - Compatibility limitations - The vendor documentation emphasizes use only with compatible ultrasound systems and warns against unsupported configurations. - Roadmap and future features - Vendor press releases reference plans to expand into additional workflows (for example, ICU and circulatory support settings). Timelines and regulatory status for future modules should be confirmed directly with the vendor. - Scale limitations and operational bottlenecks - Expanding FoCUS acquisition without proportionally scaling over-reading and QA can move or amplify existing bottlenecks rather than eliminate them. - Security and compliance documentation gaps - Public documentation of enterprise security certifications and specific security features was not located in a consolidated form; procurement should require security evidence and attestations during evaluation.

Deal disqualifiers: what makes a poor fit

Lack of ability to provide physician oversight or over-reading at deployment scale
Highly heterogeneous ultrasound fleets that cannot be standardized to compatible configurations
Expectation that the tool will replace comprehensive echocardiography or eliminate the need for trained sonographers

02Why they buy

- Key differentiators supported by evidence (where available) - The product includes an FDA-cleared module intended to assist non-expert users with acquisition of standard adult TTE views. - Peer-reviewed literature reports feasibility of novice acquisition after structured, brief training in controlled study environments. - Vendor-provided features that may differentiate the offering - The vendor presents a combined program covering training, acquisition guidance, interpretation workflow, and stewardship; this integrated framing differs from products that focus on a single AI component. - Areas where competitors have clearer advantages - Some competitors publish clearer pricing and consumer-oriented purchasing paths for individual users (for example, published probe and membership pricing). - Competitors may provide broader modality coverage or more mature middleware/reporting ecosystems.

03Field reports

Important context on review availability

UltraSight has limited presence on mainstream B2B software review platforms under the product name "UltraSight." Searches primarily returned vendor or general category pages rather than product-specific user reviews.
Public forum searches returned mostly irrelevant matches for the term "ultrasight" in some contexts, indicating limited public discussion under that name.

Accessible quotes and sentiment signals (limited direct UltraSight-user reviews found)

Product-specific end-user review quotes were not identified on major review platforms in publicly accessible pages during this research pass.
The most accessible customer-evidence signals are clinical literature and regulatory summaries rather than standard SaaS review-platform feedback.

Evidence adjacent to customer outcomes (not the same as customer reviews)

Peer-reviewed clinical literature describes studies in which novice users received brief training and used AI guidance integrated into handheld ultrasound systems, supporting feasibility of acquiring images suitable for interpretation and quantitative analysis in trial settings.

Recommended diligence to validate customer experience

- Request customer references in comparable settings (ED vs ICU vs inpatient vs outpatient screening) and investigate details such as: - Duration of training for nurses, residents, or advanced practice providers - Portion of scans meeting predefined diagnostic-quality thresholds at defined timepoints (for example, early, mid, and later adoption checkpoints) - QA burden on the echo lab (over-reads, repeat scans, false positives) - Operational friction points (device pairing, logins, DICOM routing, downtime) - Governance and liability arrangements (who signs reports, how findings are documented in the EMR)

Vendor-published clinical/white paper materials (treated as vendor-sourced)

UltraSight hosts white papers and pivotal-study analyses on its site. These materials describe study design and reported outcomes; treat vendor-published materials as vendor-provided evidence and seek independent validation where possible.

Independent clinical literature signals

- A peer-reviewed article in Circulation: Cardiovascular Imaging describes novice imagers completing brief training and using UltraSight AI-based guidance integrated into a handheld ultrasound system. - Critical considerations for generalizability: - Studies often involve controlled training and oversight that may be more structured than typical real-world staffing models. - Questions to evaluate in vendor-provided or independent studies include performance in patients with poor acoustic windows (e.g., obesity, ventilation), time-to-image metrics in high-acuity workflows, and rates of non-diagnostic scans.

Vendor press release references to external publications

The vendor referenced a JAMA Cardiology article in a financing press release. When reviewing press-release claims, read the original publication to evaluate study design, conflict-of-interest disclosures, comparator methods, blinding, selection bias, and operational workflow details.

04Best fit

Company sizes

Best fit is likely mid-to-large hospitals and multi-hospital health systems where:
- Echo labs face backlog and staffing constraints
- There is available physician capacity (cardiology/echo) to provide oversight and QA
- IT capability exists to integrate with PACS/VNA/EMR

Industries and verticals

Acute care hospitals
Critical care and emergency medicine departments
Out-of-hospital programs (community hospitals, rural clinics, home care models) that use remote interpretation

Roles and personas

- Decision makers - Cardiology leadership and echo lab directors - Chief Medical Information Officers and clinical informatics leads - ED/ICU leadership - Biomedical engineering and ultrasound program owners - Compliance and risk management leaders - End users - ICU nurses (in some FoCUS models) - ED physicians and advanced practice providers - Hospitalists - Paramedics and community clinicians (where remote interpretation is supported and local protocols permit)

Pain points and challenges the product addresses

Echo lab capacity constraints
Need for faster bedside cardiac assessment in time-sensitive settings
Skill gaps for acquiring standard echo windows among non-sonographer clinicians

Qualification criteria: what makes a strong fit

Clear governance model with protocols defining FoCUS questions and escalation paths
Ultrasound hardware that meets UltraSight compatibility requirements
Commitment to structured training and QA loops

05The pitch

What the product does (core value proposition in objective terms)

- UltraSight offers an AI-assisted cardiac workflow solution intended to expand access to focused echocardiography (FoCUS) by supporting non-sonographer clinical providers in acquiring transthoracic echocardiography images at the bedside, with qualified physician oversight. - The vendor describes the offering using the term "EchoSystem," which combines: - Structured training - Real-time AI guidance during image acquisition - Interpretation support and workflow integration - Analytics and ongoing echo lab stewardship (vendor terminology) - The component cleared by the U.S. FDA is UltraSight AI Guidance, documented in FDA materials as a mobile application that provides real-time guidance on transducer position and orientation to assist non-expert users in acquiring standard transthoracic echo views.

Target market and market positioning

- Primary customers are hospitals and health systems seeking to reduce echo lab bottlenecks and extend cardiac ultrasound capability into settings such as: - ICU / CCU - Emergency medicine - Inpatient wards - Out-of-hospital or telehealth-enabled acquisition with remote interpretation - The vendor positions the product to extend echo acquisition capacity while aiming to minimize workflow disruption and to support new and occasional users in acquiring usable images more quickly.

Get a comprehensive analysis of UltraSight including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →